LRG1 Polyclonal Antibody

The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation.

The LRG1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of Leucine-rich alpha-2-glycoprotein 1 (LRG1) in various biological samples. This antibody has been meticulously developed and validated to ensure optimal performance and reliability in a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA).

LRG1 is a secreted glycoprotein that has been implicated in various physiological and pathological processes, including inflammation, angiogenesis, and cancer progression. As such, the accurate measurement of LRG1 levels is of utmost importance in both basic research and clinical settings. The LRG1 Polyclonal Antibody offers exceptional sensitivity and specificity, enabling precise and reproducible quantification of LRG1 in complex biological matrices.

This antibody has been rigorously tested to ensure minimal cross-reactivity with other related proteins, ensuring accurate and reliable results. Its polyclonal nature allows for enhanced detection sensitivity, as multiple epitopes are recognized by the antibody, increasing the chances of successful detection even in low abundance samples.

The LRG1 Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It has been optimized for ease of use and compatibility with various experimental protocols. Its high affinity and specificity make it an ideal choice for researchers and clinicians seeking to investigate the role of LRG1 in various biological processes.

In summary, the LRG1 Polyclonal Antibody is a highly reliable and sensitive tool for the detection and quantification of LRG1 in biological samples. Its exceptional performance and versatility make it an invaluable asset for researchers and clinicians alike, enabling a deeper understanding of the role of LRG1 in health and disease.